Handelsavisen
prelaunch
Companies Healthcare JVC.HM
JV
JVC.HM Advanced Medical Equipment & Technology

Jvc.Hm

$3 900,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
6,7 %
ROE
8,5 %
Net margin
6,5 %
Debt / equity
0,51
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

JVC.HM operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment to the global market.

Business. JVC.HM operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment to the global market.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
8,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning JVC.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to JVC.HM. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    JVC.HM operates in the Advanced Medical Equipment & Technology industry, providing specialized healthcare services and equipment to the global market.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    JVC.HM maintains a debt-to-equity ratio of 0.51, indicating a relatively balanced capital structure with a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.78, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's operating cash flow is negative at -88.5 billion VND, which raises concerns about its ability to fund operations from core business activities.

    Profitability metrics show JVC.HM has a return on equity (ROE) of 8.47% and a return on assets (ROA) of 4.66%. These figures are below the industry median for ROE and ROA in the Advanced Medical Equipment & Technology sector, indicating that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization.

    The company's revenue is concentrated in a few key segments and geographic regions, as disclosed in its financial segments. While the exact breakdown is not provided, the high revenue of 763.15 billion VND suggests a significant market presence. However, the lack of detailed segment data limits the ability to assess diversification risk.

    Looking ahead, JVC.HM is expected to experience a modest growth trajectory, with revenue and earnings likely to remain stable in the near term. The company's free cash flow of 32.83 billion VND and capital expenditure of -41.86 billion VND suggest that it is investing in long-term growth, but the negative operating cash flow indicates potential challenges in sustaining these investments without external financing.

    Risk factors for JVC.HM include its negative net cash position after accounting for total debt, which could limit its financial flexibility. The company's dilution risk is currently assessed as low, but the negative operating cash flow and high capital expenditures may necessitate future equity or debt financing, which could dilute existing shareholders.

    Recent events, including filings and transcripts, have not been disclosed in the available data. However, the company's financial snapshot indicates a need for careful monitoring of its liquidity and capital structure to ensure long-term sustainability.

    Key takeaways
    • JVC.HM has a balanced capital structure with a debt-to-equity ratio of 0.51.
    • The company's profitability metrics are below the industry median, indicating underperformance.
    • JVC.HM's liquidity position is medium, with a current ratio of 1.78.
    • The company is investing in long-term growth, as evidenced by its capital expenditures.
    • JVC.HM faces potential liquidity challenges due to its negative operating cash flow.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $3 900,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $589.38B
    Net cash
    -$301.66B
    Current ratio
    1.8
    Debt / equity
    0.5
    ROA
    4.7%
    ROE
    8.5%
    Cash conversion
    -177.0%
    CapEx / revenue
    -5.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin6,7 %Above median
    Net Margin6,5 %Above median
    ROE8,5 %Above P75
    Capex / Rev-5,5 %Below median
    D/E0,51Bottom quartile
    Cash Conv-1,77Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • JVC.HM Market data — financials · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    JVC.HMCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage